Episode Details
Back to Episodes
Pharmaceutical Executive Daily: George Tidmarsh Resigns from FDA
Published 6 months, 2 weeks ago
Description
In today’s Pharmaceutical Executive Daily, we cover Eli Lilly’s plan to submit its oral GLP-1 candidate for FDA priority review, the departure of senior FDA official George Tidmarsh, and growing global venture capital investment in biopharma innovation.